Foresee Genomics
Developer of next-generation sequencing (NGS) solutions designed to enable small and medium-sized clinical laboratories to perform high-accuracy genomic diagnostics in-house. Offers integrated molecular sample-preparation kits, long-read sequencing workflows, and automated bioinformatics for rapid, lower-cost clinical testing tailored to cancer and genetic-disorder applications.
Industries
Nr. of Employees
small (1-50)
Foresee Genomics
Patents
Products
Molecular sample-preparation kits
User-friendly reagent kits and protocols for streamlined NGS library preparation and sample processing.
Integrated sequencing workflow
A sequencing workflow combining long-read sequencing with validated analysis for clinical variant detection.
Automated analysis software
Software for automated processing, interpretation, and reporting of NGS data to generate actionable clinical insights.
Foresee Genomics NGS Solutions
Comprehensive NGS solutions including protocols, reagents, and bioinformatics designed for affordable, fast, and high-precision genomic testing with minimal infrastructure requirements.
SeqF
Proprietary technology platform combining molecular biology and bioinformatics software with Nanopore sequencing technology to deliver high-precision, accurate, and reproducible variant analysis.
Molecular sample-preparation kits
User-friendly reagent kits and protocols for streamlined NGS library preparation and sample processing.
Integrated sequencing workflow
A sequencing workflow combining long-read sequencing with validated analysis for clinical variant detection.
Automated analysis software
Software for automated processing, interpretation, and reporting of NGS data to generate actionable clinical insights.
Foresee Genomics NGS Solutions
Comprehensive NGS solutions including protocols, reagents, and bioinformatics designed for affordable, fast, and high-precision genomic testing with minimal infrastructure requirements.
SeqF
Proprietary technology platform combining molecular biology and bioinformatics software with Nanopore sequencing technology to deliver high-precision, accurate, and reproducible variant analysis.
Services
Delivery of end-to-end NGS capabilities including protocols, reagents, sequencing workflows, and automated analysis to enable in-house genomic testing.
Assistance and validated workflows for deploying diagnostic assays and meeting clinical laboratory standards.
Delivery of end-to-end NGS capabilities including protocols, reagents, sequencing workflows, and automated analysis to enable in-house genomic testing.
Assistance and validated workflows for deploying diagnostic assays and meeting clinical laboratory standards.
Expertise Areas
- Clinical next-generation sequencing diagnostics
- Bioinformatics automation and clinical reporting
- NGS workflow development and laboratory implementation
- Analytical validation for low-frequency variant detection
Key Technologies
- Long-read (Nanopore) sequencing
- NGS library preparation kits
- Automated bioinformatics pipelines
- Variant calling and low-allele-frequency detection
News & Updates
Published validation data showing consistent alignment with expected variant allele frequencies and reproducible detection of low-frequency mutations across independent sequencing runs and platforms.
Published validation data showing consistent alignment with expected variant allele frequencies and reproducible detection of low-frequency mutations across independent sequencing runs and platforms.